+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Argentina Probiotics Market - Forecasts from 2022 to 2027

  • PDF Icon


  • 75 Pages
  • January 2023
  • Region: Argentina
  • Knowledge Sourcing Intelligence LLP
  • ID: 5743389
The Argentina probiotics market is anticipated to expand at a CAGR of 7.97% over the course of the forecast period, from US$0.442 billion in 2020 to a total market value of US$0.756 billion by 2027.

Live microorganisms known as probiotics are intended to improve one's health whether taken orally or topically. Yogurts, other fermented foods, and probiotic-rich beverages are widely available and provide delicious, nutrient-dense snacks. Probiotics are also found in many cosmetic products. When consumed in appropriate amounts, probiotics have beneficial effects on the body, including improved gut health and reduced intestinal inflammation. Since they improve immune function and halt the progression of diseases, probiotics are crucial for preventative healthcare.

Growing Health concerns for humans and animals is anticipated to boost the market

The demand for natural health-beneficial products increased consumer knowledge of the value of preventative healthcare, and rising disposable income is expected to drive growth in the Argentine probiotics market. Probiotics are used in dietary supplements such as infant formula, food supplements, nutritional supplements, and specialty nutrients as the demand for dietary supplements rise as a result of rising fitness aspirations among individuals. The demand for probiotics in functional food and beverages has increased as a result of rising processed food consumption, unhealthy lifestyle choices, and increased media and health authority coverage of nutrition and the relationship between diet and health. Probiotics are added to feed to increase animal weight gain and feed effectiveness as well as to preserve and advance the well-being of domestic animals and poultry. Additionally, the inclusion of probiotics in a variety of foods, beverages, and medications is quickly creating a fantastic investment opportunity in the Country.

Market Developments:

  • May 2021: Leading international bioscience business Chr. Hansen introduced a new product to the Argentine market to give dairy producers access to a technology that has been shown to improve herd productivity and gut health. Bacillus licheniformis and Bacillus subtilis, two strains of distinct Bacilli species that were obtained from nature, make up the probiotic BovacillusTM. Because Bacillus spores can endure challenging conditions during the production, preparation, and gastrointestinal tract of feed, BovacillusTM is a unique kind of probiotic. BovacillusTM is an efficient probiotic that can be utilized in a wide range of cattle applications, including premixes, mineral mixes, mashed feed, pellets and cubes, milk substitutes, pasteurized milk, complete feed, blocks and tubs, and liquids.
  • August 2022: Argentina's most well-known kinds of leaders, including e-commerce billionaire Marcos Galperin and pharmaceutical tycoon Hugo Sigman, announced pledging additional funding for the biotech accelerator GridX, based in the country's capital city of Buenos Aires. The $50 million target for the new fund is being raised by the accelerator. The Food4You by GridX uses fermentation with lactic acid bacteria to enhance plant-based foods with particular strains that can enhance flavour, texture, and aroma as well as people's health because they are biofactories, which means they can produce compounds of interest, such as vitamins and antioxidants, as well as probiotic potential. The Company’s main goal is to create a biotechnological platform that designs and optimizes the combination of plant substrates with a library of distinct strains that have been extensively researched to improve nutritional and functional quality, offering tailored answers to each plant-based proposal.

Product Offerings:

  • Calsporin®: Bacillus velezensis DSM 15544 is a spore-forming probiotic found in Calsporin®. It has been demonstrated that adding Bacillus velezensis DSM 15544 to the diets of piglets and broiler chickens improves growth and feed conversion. Multiple mechanisms are used by Bacillus velezensis DSM 15544 (Calsporin®) to enhance gut health. There is a large variety of microflora in the stomach, including both beneficial and harmful microorganisms (pathogens like Clostridia, E. Coli, Salmonella, Campylobacter). By consuming oxygen, producing enzymes, and excluding competitors, Bacillus velezensis develops a favorable environment for the good bacteria in the gut. A healthier gut is the end outcome, and a healthier gut leads to improved food absorption, fewer digestive issues, healthier animals, and better performance.
  • Floramax B11: Ventaco's Floramax B11 Probiotic is a probiotic blend of carefully chosen lactobacillus. It is utilised for purposes like probiotics for poultry. It competes with pathogen flora to produce favorable effects on the host and, as a result, better production parameters. It comes in containers of 30, 60, and 140 g. A bottle containing 140 g of the medication can treat 25.000 birds. The necessary volume is calculated based on the number of birds to treat, together with the amount of water needed to supply the product for 12 to 16 hours. It is advised to take it weekly, after receiving antibiotic treatment, or for three straight days.

Market Segmentation:

By Ingredient

  • Bacteria
  • Lactobacilli
  • Bifidobacterium
  • Streptococcus thermophilus
  • Yeast
  • Saccharomyces boulardii
  • Others

By Form

  • Liquid
  • Dry

By Application

  • Functional Food and Beverages
  • Dietary Supplements
  • Animal Feed

By End-User

  • Human
  • Animal

Table of Contents

1.1. Market Overview
1.2. COVID-19 Scenario
1.3. Market Definition
1.4. Market Segmentation

2.1. Research Data
2.2. Assumptions

3.1. Research Highlights

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5.1. Introduction
5.2. Bacteria
5.2.1. Lactobacilli
5.2.2. Bifidobacterium
5.2.3. Streptococcus Thermophilus
5.3. Yeast
5.4. Saccharomyces Boulardii
5.5. Others

6.1. Introduction
6.2. Liquid 
6.3. Dry

7.1. Introduction
7.2. Functional Food and Beverages
7.3. Dietary Supplements
7.4. Animal Feed

8.1. Introduction
8.2. Human
8.3. Animal 

9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix

10.1. Orfaa
10.2. Mastellone Hnos SA
10.3. Vetanco
10.4. Progurt
*Not an exhaustive list

Companies Mentioned

  • Orffa
  • Mastellone Hnos SA
  • Vetanco.
  • Progurt Inc.



Table Information